フランスのバイオテクノロジー企業TreeFrog Therapeuticsが神戸に進出、iPS 細胞治療の大量生産に向けた新技術の導入推進を目指す

TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and...